My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 81

    1.

    Longer rodent bioassay fails to address 2-year bioassay's flaws.

    Manuppello J, Willett C.

    Environ Health Perspect. 2008 Dec;116(12):A516-7; author reply A517-8. No abstract available. PMID: 19079693 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard.

    Tennant RW.

    Mutat Res. 1993 Mar;286(1):111-8. Review.PMID: 7678907 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prevention versus chemophobia: a defence of rodent carcinogenicity tests.

    Infante PF.

    Lancet. 1991 Mar 2;337(8740):538-40. No abstract available. PMID: 1671901 [PubMed - indexed for MEDLINE]Related articles

    4.

    Review of alternative methods of carcinogenicity testing and evaluation of human pharmaceuticals.

    Van Deun K, Van Cauteren H, Vandenberghe J, Canning M, Vanparys P, Coussement W.

    Adverse Drug React Toxicol Rev. 1997 Nov;16(4):215-33. Review.PMID: 9608857 [PubMed - indexed for MEDLINE]Related articles

    5.

    Alternatives to the 2-species bioassay for the identification of potential human carcinogens.

    Ashby J.

    Hum Exp Toxicol. 1996 Mar;15(3):183-202. Review.PMID: 8839204 [PubMed - indexed for MEDLINE]Related articles

    6.

    Animal carcinogenicity studies: 3. Alternatives to the bioassay.

    Knight A, Bailey J, Balcombe J.

    Altern Lab Anim. 2006 Feb;34(1):39-48.PMID: 16522149 [PubMed - indexed for MEDLINE]Related articles

    7.

    Methodologies for interpretation of short-term test results which may allow reduction in the use of animals in carcinogenicity testing.

    Ennever FK, Rosenkranz HS.

    Toxicol Ind Health. 1988 Jun;4(2):137-49. Review.PMID: 3140422 [PubMed - indexed for MEDLINE]Related articles

    8.

    Historical review of the rodent bioassay and future directions.

    McConnell EE.

    Regul Toxicol Pharmacol. 1995 Feb;21(1):38-43; discussion 81-6. No abstract available. PMID: 7784634 [PubMed - indexed for MEDLINE]Related articles

    9.

    Design and evaluation of rodent carcinogenicity studies (bioassay).

    Usui T.

    J Toxicol Sci. 1995 Sep;20(4):457-8. No abstract available. PMID: 8531240 [PubMed - indexed for MEDLINE]Related articles

    10.

    In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals.

    Contrera JF, DeGeorge JJ.

    Environ Health Perspect. 1998 Feb;106 Suppl 1:71-80. Review.PMID: 9539006 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Accelerated rodent bioassay predictive of chemical carcinogenesis.

    Iatropoulos MJ.

    Exp Toxicol Pathol. 1992 Dec;44(8):481-7. No abstract available. PMID: 1493367 [PubMed - indexed for MEDLINE]Related articles

    12.

    NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies).

    National Toxicology Program.

    Natl Toxicol Program Tech Rep Ser. 2005 Oct;(528):1-190.PMID: 16362062 [PubMed - indexed for MEDLINE]Related articles

    13.

    Use of rodent carcinogenicity test results for determining potential cancer risk to humans.

    Infante PF.

    Environ Health Perspect. 1993 Dec;101 Suppl 5:143-8. Review.PMID: 8013402 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    IFSTP guidelines for the design and interpretation of the chronic rodent carcinogenicity bioassay.

    Faccini JM, Butler WR, Friedmann JC, Hess R, Reznik GK, Ito N, Hayashi Y, Williams GM.

    Exp Toxicol Pathol. 1992 Dec;44(8):443-56. No abstract available. PMID: 1493363 [PubMed - indexed for MEDLINE]Related articles

    15.

    Performance of 133 compounds in the lambda prophage induction endpoint of the Microscreen assay and a comparison with S. typhimurium mutagenicity and rodent carcinogenicity assays.

    Rossman TG, Molina M, Meyer L, Boone P, Klein CB, Wang Z, Li F, Lin WC, Kinney PL.

    Mutat Res. 1991 Aug;260(4):349-67.PMID: 1831244 [PubMed - indexed for MEDLINE]Related articles

    16.

    Assessment of immunosuppressant drug carcinogenicity: standard and alternative animal models.

    Hastings KL.

    Hum Exp Toxicol. 2000 Apr;19(4):261-5. Review.PMID: 10918520 [PubMed - indexed for MEDLINE]Related articles

    17.

    The OECD program to validate the rat uterotrophic bioassay: an overview.

    Owens W, Koëter HB.

    Environ Health Perspect. 2003 Sep;111(12):1527-9.PMID: 12948895 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Lung tumors in strain A mice as a bioassay for carcinogenicity of environmental chemicals.

    Stoner GD.

    Exp Lung Res. 1991 Mar-Apr;17(2):405-23.PMID: 2050040 [PubMed - indexed for MEDLINE]Related articles

    19.

    Application of the carcinogenicity prediction and battery selection method to recent National Toxicology Program short-term test data.

    Ennever FK, Rosenkranz HS.

    Environ Mol Mutagen. 1989;13(4):332-8.PMID: 2737184 [PubMed - indexed for MEDLINE]Related articles

    20.

    Predicting chemical carcinogenesis in rodents.

    Wachsman JT, Bristol DW, Spalding J, Shelby M, Tennant RW.

    Environ Health Perspect. 1993 Oct;101(5):444-5. No abstract available. PMID: 8119256 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity